Eledon Pharmaceuticals, Inc. — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| BVF INC/IL | — | Purchase | 75,431 | — | — | 220,460 | May 9, 2024 |
| Biotechnology Value Trading Fund OS LP | — | Purchase | 1,055,445 | — | — | 2,330,418 | May 5, 2023 |
| Perrin Steven | President | Purchase | 1,000 | $2.60 | $2,600 | 1,000 | Nov 23, 2022 |
| Gros David-Alexandre C | Chief Executive Officer | Purchase | 2,000 | $4.48 | $8,960 | 9,000 | Dec 20, 2021 |
| Gros David-Alexandre C | Chief Executive Officer | Purchase | 4,000 | $6.21 | $24,840 | 7,000 | Aug 17, 2021 |
| Little Paul Sean | CHIEF FINANCIAL OFFICER | Purchase | 10,000 | $8.87 | $88,700 | 10,000 | Jun 11, 2021 |
| Gros David-Alexandre C | Chief Executive Officer | Purchase | 3,000 | $8.01 | $24,030 | 3,000 | Jun 9, 2021 |
| LAMPERT MARK N | — | C | 11,278 | — | — | 89,214 | Dec 22, 2020 |
| OrbiMed Israel GP Ltd. | — | Sale | 103,200 | $21.60 | $2,229,120 | 73,650 | Dec 2, 2020 |
| Logos Global Management LP | — | Sale | 12,942 | $26.64 | $344,775 | 187,058 | Oct 30, 2020 |
| TURKEL CATHERINE C. | President | Sale | 7,623 | $1.96 | $14,941 | 90,576 | May 21, 2019 |
| Kuwahara Jon | See Remarks | Sale | 4,218 | $1.96 | $8,267 | 7,032 | May 21, 2019 |
| FLESHER GREGORY J. | Chief Executive Officer | Sale | 2,937 | $1.91 | $5,610 | 156,918 | May 20, 2019 |
| OrbiMed Israel BioFund GP Limited Partnership | — | Purchase | 646,204 | $3.10 | $2,003,232 | 3,183,314 | May 2, 2019 |
| Chimovits Erez | — | Purchase | 646,204 | $3.10 | $2,003,232 | 3,183,314 | May 2, 2019 |
| YOOK PAUL | — | Sale | 200 | $2.70 | $540 | 1,065,867 | Apr 30, 2019 |
| TURKEL CATHERINE C. | President | Award / Grant | 20,000 | — | — | 98,199 | Mar 14, 2019 |
| FLESHER GREGORY J. | Chief Executive Officer | Award / Grant | 25,000 | — | — | 171,556 | Mar 14, 2019 |
| TURKEL CATHERINE C. | President | Purchase | 16,632 | $5.02 | $83,493 | 78,199 | Sep 11, 2018 |
| TURKEL CATHERINE C. | President | Purchase | 805 | $3.97 | $3,196 | 805 | Sep 5, 2018 |
| Kuwahara Jon | See Remarks | Award / Grant | 11,250 | — | — | 11,250 | Mar 13, 2018 |
| FLESHER GREGORY J. | Chief Executive Officer | Award / Grant | 30,700 | — | — | 146,556 | Mar 13, 2018 |
| TURKEL CATHERINE C. | President | Award / Grant | 20,000 | — | — | 44,519 | Mar 13, 2018 |
| FLESHER GREGORY J. | Chief Executive Officer | Purchase | 58,959 | $9.99 | $589,000 | 115,856 | May 10, 2017 |
| TURKEL CATHERINE C. | Chief Development Officer | Purchase | 11,111 | $9.99 | $110,999 | 24,519 | May 10, 2017 |
| OCAMPO CHRISTINE | See Remarks | Purchase | 10,010 | $9.99 | $100,000 | 21,590 | May 10, 2017 |
| OrbiMed Israel BioFund GP Limited Partnership | — | Award / Grant | 2,537,110 | — | — | 2,537,110 | May 9, 2017 |
| Buckley Stephen Jr. | — | Purchase | 8,000 | $5.74 | $45,920 | 11,000 | Mar 15, 2016 |
| Morrison Jodie Pope | President and CEO | Option Exercise | 20,000 | $1.37 | $27,400 | 57,566 | Jan 8, 2016 |
| Buckley Stephen Jr. | — | Purchase | 3,000 | $11.25 | $33,750 | 3,000 | Nov 11, 2015 |
| McBride John S. | Chief Operating Officer | Option Exercise | 13,500 | $4.19 | $56,565 | 13,500 | Sep 21, 2015 |
| Kalowski Lee | Chief Financial Officer | Sale | 4,668 | $13.13 | $61,291 | 40,953 | Sep 8, 2015 |
| Kalowski Lee | Chief Financial Officer | Sale | 2,158 | $12.96 | $27,968 | 45,621 | Sep 2, 2015 |
| Morrison Jodie Pope | President and CEO | Sale | 12,000 | $13.70 | $164,400 | 19,551 | Jul 28, 2015 |
| Morrison Jodie Pope | President and CEO | Option Exercise | 2,574 | $2.31 | $5,946 | 12,125 | Jul 22, 2015 |
| NOVARTIS AG | — | Sale | 3,566 | $14.26 | $50,851 | 4,493,458 | Jul 15, 2015 |
| NOVARTIS AG | — | Sale | 27,861 | $14.41 | $401,477 | 4,497,024 | Jul 13, 2015 |
| Morrison Jodie Pope | President and CEO | Sale | 8,000 | $13.70 | $109,600 | 9,551 | Jun 26, 2015 |
| McBride John S. | Chief Operating Officer | Sale | 300 | $14.20 | $4,260 | — | Jun 22, 2015 |
| Novartis Bioventures Ltd | — | Sale | 1,120 | $14.27 | $15,982 | 4,545,496 | Jun 16, 2015 |
| Novartis Bioventures Ltd | — | Sale | 27,875 | $14.20 | $395,825 | 4,567,312 | Jun 11, 2015 |
| Kalowski Lee | Chief Financial Officer | Sale | 4,567 | $13.00 | $59,371 | 47,779 | Apr 16, 2015 |
| Kalowski Lee | Chief Financial Officer | Sale | 2,258 | $11.45 | $25,854 | 52,346 | Apr 2, 2015 |
| NOVARTIS AG | — | Sale | 46,141 | $14.50 | $669,045 | 4,595,187 | Mar 18, 2015 |
| BARBERICH TIMOTHY J | — | C | 121,077 | — | — | 121,077 | Sep 22, 2014 |
| NOVARTIS AG | — | C | 4,319,328 | — | — | 4,319,328 | Sep 22, 2014 |
| Harrison Seth Loring | — | C | 7,549,570 | — | — | 7,549,579 | Sep 22, 2014 |
| APPLE TREE PARTNERS II LP | — | C | 4,218,632 | — | — | 4,218,641 | Sep 22, 2014 |
| Apple Tree Partners II - Annex, L.P. | — | Purchase | 237,500 | $15.00 | $3,562,500 | 3,568,438 | Sep 22, 2014 |
| Satter Muneer A | — | Purchase | 150,000 | $15.00 | $2,250,000 | 1,771,688 | Sep 22, 2014 |